Could Risk Stratifying MTX Users Lead to Testing Less Often?

A new prognostic model accurately predicts a patient’s risk of experiencing methotrexate toxicity, but more research is needed before clinical application, experts say.

Related Keywords

Nottingham ,United Kingdom ,California ,United States ,Abhishek ,Los Angeles ,Prabha Ranganathan ,Daniele Furst ,Nottingham University Hospitals ,University Of California ,United Kingdom Clinical Practice Research Datalink ,More Research ,Washington University School Of Medicine ,Clinical Practice Research Datalink ,Medscape Medical News ,Hospital Rheumatoid Arthritis Sequential Study ,Washington University School ,Toxicology ,Blood ,Complete Blood Count Cbc ,Ull Blood Count Fbc ,Ull Blood Exam Fbe ,Blood Panel ,United Kingdom Site Content ,Rheumatoid Arthritis ,A ,Uk National Health Service ,United Kingdom National Health Service ,K Nhs ,Dhs ,National Health Service ,Chronic Renal Failure ,Hronic Kidney Failure ,Hronic Kidney Disease Ckd ,Chronic Kidney Disease ,Kd ,Renal Failure ,Enal Insufficie ,